Alport Foundation of Australia
 

Privacy Policy             Disclaimer            Sitemap         Copyright ® 2010 Alport Foundation of Australia, Inc. All Rights Reserved 

Graphic kindly provided by Zygote Media Group, Inc.    www.Zygote.com     www.3DScience.com          Alport Foundation of Australia: ABN 87 956 459 275

RELATED WEBSITES

www.alportsyndrome.org

This is the website of the US Alport Foundation. It is linked to the Alport Syndrome Treatments

and Outcomes Registry (ASTOR) and has contact details for genetic testing laboratories

worldwide and for kidney and skin immunohistochemistry in North America.


www.actionforalportscampaign.org

United Kingdom–based patient support group that provides information for families

affected by Alport syndrome and brings together professionals with a particular

interest in the condition.


www.alportregistry.org

ASTOR is a voluntary international patient registry established at the University of

Minnesota that aims to provide patients and families with the most current information

about Alport syndrome. Information from this registry will be used to design future

treatments.


www.orpha.net/consor/cgi-bin/OC_Exp.php?Expert=63&lng=EN

Alport Orphanet is a mainly European-centric site that describes the disease classifications;

lists recent medical publications; links to other relevant websites; and gives contact

details for expert treating centers, diagnostic testing laboratories, patient support

groups, funding groups, research projects, clinical trials and registries, biobanks and

networks.


www.arup.utah.edu/database/ALPORT/ALPORT_welcome.php


www.grenada.lumc.nl/LOVD2/COL4A/home.php?select_db=COL4A3

These curated COL4A5 mutation databases are hosted by the LOVD and ARUP Laboratories.


www.ncbi.nlm.nih.gov/books/NBK22183

This useful and comprehensive overview of Alport syndrome from NCBI provides specific genetic information clearly described for each form of inheritance.


www.alport.de

This is a voluntary international patient registry established at the University of Goettingen,

Germany.


www.alport.de/EARLY PRO-TECT

This website has information about the phase III, multicenter, randomized, double-blind, placebo-controlled trial to investigate the optimal timing of ACE inhibitor therapy and its safety in pediatric patients with early-stage disease.

ASTOR, Alport Syndrome Treatments and Outcomes Registry; LOVD, Leiden Open Variation Database; NCBI, National Center for Biomedical Information




Email info@alport.org.au if you know of any other helpful websites to add to this list